查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1751191

透明質酸市場規模、佔有率、趨勢分析報告：按應用、地區和細分市場預測，2025 年至 2030 年

Hyaluronic Acid Market Size, Share & Trends Analysis Report By Application (Dermal Fillers, Osteoarthritis, Ophthalmic, Vesicoureteral Reflux), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

透明質酸市場成長與趨勢：

根據 Grand View Research, Inc. 的新報告，全球透明質酸市場規模預計到 2030 年將達到 167 億美元，2025 年至 2030 年的複合年成長率為 7.81%。

人們對化學品日益成長的興趣、對快速顯著效果的渴望以及更短的恢復時間等因素，是高效渲染的促進因素。由於已開發國家和開發中地區擴大採用美容手術，該行業正在快速發展。為了提高相容性，透明質酸表面在心血管植入（如支架和血管移植物）中的應用日益增多，加上人們對抗衰老產品的認知不斷提高，這些因素推動了該行業的發展。

透明質酸類真皮填充劑的有效性和顯著效果正吸引著這個群體。此外，新冠疫情改變了許多行業的動態，出行限制、保持社交距離以及對實踐的重新審視成為「新常態」。隨著美容行業逐步恢復營運，許多醫生表示，美容手術的諮詢量顯著增加。此外，隔離也促使專業人士使用視訊會議設備，讓人們更重視自己的形象。在某些情況下，人們選擇接受美容療程。這被稱為“Zoom熱潮”或“Zoom效應”。

受疫情影響，全球整形外科醫師的患者數量顯著增加，尤其是在美國、澳洲和日本等國家。 2022年，北美佔據了最大的收入佔有率。儘管價格昂貴，但患者更傾向於短期治療方法，以及骨關節炎等目標疾病的流行是其高佔有率的主要因素。 2022年，北美地區最賺錢的產品應用是用於治療骨關節炎的真皮填充劑和黏性補充劑。預計亞太地區在預測期內的複合年成長率將最快。

中國和日本的老年人口不斷成長，為抗衰老產品和服務提供了龐大的基本客群。人們對產品用途和功效的認知不斷提高，也推動了需求的成長。此外，可支配所得水準的提高也進一步推動了該地區的擴張。歐洲在過去兩年中發生了顯著的變化。不斷成長的需求導致新參與企業的價格競爭加劇。世界衛生組織最近公佈了英國和德國的肥胖症流行。老化人口成長與肥胖之間的關係是歐洲區域產業的潛在驅動力。

透明質酸市場報告重點

  • 真皮填充劑領域將佔據市場主導地位，到 2024 年將佔據 41.82% 的最大收益佔有率。
  • 北美將主導市場，到 2024 年將佔據 42.08% 的佔有率。透明質酸市場的發展受到抗衰老治療需求的增加、骨關節炎患者數量的增加以及對微創手術認知的不斷提高的推動。
  • 美國透明質酸市場正在經歷強勁成長，這得益於非手術美容程序的需求不斷成長以及醫療應用的進步，特別是基於透明質酸的真皮填充劑。
  • 預計預測期內亞太地區透明質酸市場將以 8.25% 的複合年成長率成長…

目錄

第1章調查方法與範圍

第2章執行摘要

第3章透明質酸市場變數、趨勢與範圍

  • 市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析-波特五力分析
    • PESTEL分析
    • 管道分析
    • 專利到期分析
    • 定價分析

第4章透明質酸市場：用途預測與趨勢分析

  • 2024 年及 2030 年各應用領域的市場佔有率
  • 應用程式細分儀表板
  • 市場規模、預測與趨勢分析（按應用，2018-2030 年）
    • 真皮填充劑
    • 骨關節炎
    • 眼科
    • 膀胱輸尿管逆流症

第5章透明質酸市場：區域估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 市場規模、預測趨勢分析，2018 年至 2030 年：
  • 北美洲
    • 2018-2030年各國情況
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭態勢

  • 參與者概覽
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/列表
    • Allergan
    • Sanofi
    • Genzyme Corporation
    • Anika Therapeutics, Inc.
    • Salix Pharmaceuticals
    • Seikagaku Corporation
    • F. Hoffmann-La Roche Ag
    • Galderma Laboratories LP
    • Zimmer Biomet
    • Smith &Nephew Plc
    • Ferring BV
    • Lifecore Biomedical, Llc
    • HTL Biotechnology
    • Shiseido Company, Limited
    • Bloomage Biotechnology Corporation Limited
    • LG Life Sciences Ltd（LG Chem.）
    • Maruha Nichiro, Inc.
Product Code: 978-1-68038-333-1

Hyaluronic Acid Market Growth & Trends:

The global hyaluronic acid market size is expected to reach USD 16.7 billion by 2030, registering a CAGR of 7.81% from 2025 to 2030, according to a new report by Grand View Research, Inc. Factors, such as increasing concern of population regarding chemicals, desire to get quick and evident results, and shorter recovery time are high impact rendering drivers. The industry is evolving rapidly due to the increasing adoption of aesthetic procedures in developed and developing regions. Increasing the use of hyaluronic acid surfaces in cardiovascular implants, such as stents and vascular grafts, for improving compatibility coupled with the growing awareness about anti-aging products is fueling the growth.

The efficacy and evident results of hyaluronic acid-based dermal fillers are attracting this population base. Furthermore, the COVID-19 pandemic has changed the dynamics of many industries, with movement restrictions, social distancing, and revised practices becoming the "new normal." As the cosmetic industry is gradually resuming its operations, a number of doctors have reported a significant increase in inquiries for aesthetic surgeries. Moreover, the lockdown has encouraged all professionals to use video-conferencing facilities, which has made people more conscious of their looks. In some cases, it has led people to opt for cosmetic treatments; this is termed the "Zoom Boom" or the "Zoom effect."

Cosmetic surgeons across the world have witnessed a significant increase in the number of patients as a result of the pandemic, particularly in countries, such as the U.S., Australia, and Japan. North America held the maximum revenue share in 2022. Preference for short-treatment regimens, even though high-priced, and the prevalence of target diseases, such as osteoarthritis, are the key factors attributed to the high share. In 2022, the most lucrative product applications in the North America region were in the form of dermal fillers and viscos supplements for the management of osteoarthritis. Asia Pacific is anticipated to register the fastest CAGR during the forecast period.

The growing geriatric population in China and Japan provide a large customer base for anti-aging products and services. Rising awareness about product applications and efficacy also fuels the demand. In addition, increasing disposable income levels are further supporting the region's expansion. Europe has undergone impressive changes over the last 2 years. The growing demand is witnessing increasing price competition owing to new entrants. The WHO recently announced the obesity epidemic in the U.K. and Germany. The relationship between the increasing aging population and obesity is a potential driver for the Europe regional sector

Hyaluronic Acid Market Report Highlights:

  • The dermal fillers segment dominated the market and obtained the largest revenue share of 41.82% in 2024.
  • North America dominated the market and accounted for 42.08% share in 2024. The hyaluronic acid market is driven by increasing demand for anti-aging treatments, rising osteoarthritis cases, and growing awareness of minimally invasive procedures.
  • The U.S. hyaluronic acid market is experiencing robust growth, driven by increasing demand for non-surgical aesthetic procedures and advancements in medical applications, particularly hyaluronic acid-based dermal fillers.
  • APAC hyaluronic acid market is anticipated grow with a CAGR of 8.25% over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
  • 1.8. List of Secondary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Hyaluronic Acid Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrant
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Hyaluronic Acid Market: Application Estimates & Trend Analysis

  • 4.1. Application Market Share, 2024 & 2030
  • 4.2. Application Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analyses, By Application, 2018 to 2030
    • 4.3.1. Dermal fillers
      • 4.3.1.1. Dermal fillers Market 2018 - 2030 (USD Million)
    • 4.3.2. Osteoarthritis
      • 4.3.2.1. Osteoarthritis Market 2018 to 2030 (USD Million)
      • 4.3.2.2. Single-injection
        • 4.4.2.2.1 Single injection Market 2018 to 2030 (USD Million)
      • 4.3.2.3. Three-injection
        • 4.4.2.3.1. Three injection Market 2018 to 2030 (USD Million)
      • 4.3.2.4. Five-injection
        • 4.4.2.3.1. Five injection Market 2018 to 2030 (USD Million)
    • 4.4.3. Ophthalmic
      • 4.4.3.3. Ophthalmic Market 2018 to 2030 (USD Million)
    • 4.4.4. Vesicoureteral reflux
      • 4.4.2.3. Vesicoureteral reflux Market 2018 to 2030 (USD Million)

Chapter 5. Hyaluronic Acid Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Share Analysis, 2024 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.4. North America
    • 5.5.1. North America Hyaluronic Acid Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 5.5.2. U.S.
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/
      • 5.5.1.3. Reimbursement structure
      • 5.5.1.4. U.S. Hyaluronic Acid market 2018 to 2030 (USD Million)
    • 5.5.3. Canada
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework
      • 5.5.1.3. Reimbursement structure
      • 5.5.1.4. Canada Hyaluronic Acid market 2018 to 2030 (USD Million)
    • 5.5.4. Mexico
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework
      • 5.5.1.3. Reimbursement structure
      • 5.5.1.4. Mexico Hyaluronic Acid market 2018 to 2030 (USD Million)
  • 5.5. Europe
    • 5.5.1. Europe Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. UK
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Regulatory Framework
      • 5.5.2.3. Reimbursement Framework
      • 5.5.2.4. UK Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Germany
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Regulatory Framework
      • 5.5.3.3. Reimbursement Framework
      • 5.5.3.4. Germany Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. France
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Regulatory Framework
      • 5.5.4.3. Reimbursement Framework
      • 5.5.4.4. France Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.5. Italy
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Regulatory Framework
      • 5.5.5.3. Reimbursement Framework
      • 5.5.5.4. Italy Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.6. Spain
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Regulatory Framework
      • 5.5.6.3. Reimbursement Framework
      • 5.5.6.4. Spain Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.7. Denmark
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Regulatory Framework
      • 5.5.7.3. Reimbursement Framework
      • 5.5.7.4. Denmark Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.8. Sweden
      • 5.5.8.1. Key Country Dynamics
      • 5.5.8.2. Regulatory Framework
      • 5.5.8.3. Reimbursement Framework
      • 5.5.8.4. Sweden Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.9. Norway
      • 5.5.9.1. Key Country Dynamics
      • 5.5.9.2. Regulatory Framework
      • 5.5.9.3. Reimbursement Framework
      • 5.5.9.4. Norway Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Asia Pacific
    • 5.6.1. Asia Pacific Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. Japan
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Regulatory Framework
      • 5.6.2.3. Reimbursement Framework
      • 5.6.2.4. Japan Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. China
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Regulatory Framework
      • 5.6.3.3. Reimbursement Framework
      • 5.6.3.4. China Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. India
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Regulatory Framework
      • 5.6.4.3. Reimbursement Framework
      • 5.6.4.4. India Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.5. Australia
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Regulatory Framework
      • 5.6.5.3. Reimbursement Framework
      • 5.6.5.4. Australia Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.6. South Korea
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Regulatory Framework
      • 5.6.6.3. Reimbursement Framework
      • 5.6.6.4. South Korea Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.7. Thailand
      • 5.6.7.1. Key Country Dynamics
      • 5.6.7.2. Regulatory Framework
      • 5.6.7.3. Reimbursement Framework
      • 5.6.7.4. Thailand Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Latin America
    • 5.7.1. Latin America Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.2. Brazil
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Regulatory Framework
      • 5.7.2.3. Reimbursement Framework
      • 5.7.2.4. Japan Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.7.3. Argentina
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Regulatory Framework
      • 5.7.3.3. Reimbursement Framework
      • 5.7.3.4. China Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Middle East and Africa
    • 5.8.1. Middle East and Africa Hyaluronic Acid Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 5.8.2. South Africa
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Regulatory Framework
      • 5.8.2.3. Reimbursement Framework
      • 5.8.2.4. South Africa Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.3. Saudi Arabia
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Regulatory Framework
      • 5.8.3.3. Reimbursement Framework
      • 5.8.3.4. Saudi Arabia Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.4. UAE
      • 5.8.4.1. Key Country Dynamics
      • 5.8.4.2. Regulatory Framework
      • 5.8.4.3. Reimbursement Framework
      • 5.8.4.4. UAE Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.8.5. Kuwait
      • 5.8.5.1. Key Country Dynamics
      • 5.8.5.2. Regulatory Framework
      • 5.8.5.3. Reimbursement Framework
      • 5.8.5.4. Kuwait Hyaluronic Acid Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Participant Overview
  • 6.2. Company Market Position Analysis
  • 6.3. Company Categorization
  • 6.4. Strategy Mapping
  • 6.5. Company Profiles/Listings
    • 6.5.1. Allergan
      • 6.5.1.1. Company overview
      • 6.5.1.2. Financial performance
      • 6.5.1.3. Product benchmarking
      • 6.5.1.4. Strategic initiatives
    • 6.5.2. Sanofi
      • 6.5.2.1. Company overview
      • 6.5.2.2. Financial performance
      • 6.5.2.3. Product benchmarking
      • 6.5.2.4. Strategic initiatives
    • 6.5.3. Genzyme Corporation
      • 6.5.3.1. Company overview
      • 6.5.3.2. Financial performance
      • 6.5.3.3. Product benchmarking
      • 6.5.3.4. Strategic initiatives
    • 6.5.4. Anika Therapeutics, Inc.
      • 6.5.4.1. Company overview
      • 6.5.4.2. Financial performance
      • 6.5.4.3. Product benchmarking
      • 6.5.4.4. Strategic initiatives
    • 6.5.5. Salix Pharmaceuticals
      • 6.5.5.1. Company overview
      • 6.5.5.2. Financial performance
      • 6.5.5.3. Product benchmarking
      • 6.5.5.4. Strategic initiatives
    • 6.5.6. Seikagaku Corporation
      • 6.5.6.1. Company overview
      • 6.5.6.2. Financial performance
      • 6.5.6.3. Product benchmarking
      • 6.5.6.4. Strategic initiatives
    • 6.5.7. F. Hoffmann-La Roche Ag
      • 6.5.7.1. Company overview
      • 6.5.7.2. Financial performance
      • 6.5.7.3. Product benchmarking
      • 6.5.7.4. Strategic initiatives
    • 6.5.8. Galderma Laboratories L.P.
      • 6.5.8.1. Company overview
      • 6.5.8.2. Financial performance
      • 6.5.8.3. Product benchmarking
      • 6.5.8.4. Strategic initiatives
    • 6.5.9. Zimmer Biomet
      • 6.5.9.1. Company overview
      • 6.5.9.2. Financial performance
      • 6.5.9.3. Product benchmarking
      • 6.5.9.4. Strategic initiatives
    • 6.5.10. Smith & Nephew Plc
      • 6.5.10.1. Company overview
      • 6.5.10.2. Financial performance
      • 6.5.10.3. Product benchmarking
      • 6.5.10.4. Strategic initiatives
    • 6.5.11. Ferring B.V.
      • 6.5.11.1. Company overview
      • 6.5.11.2. Financial performance
      • 6.5.11.3. Product benchmarking
      • 6.5.11.4. Strategic initiatives
    • 6.5.12. Lifecore Biomedical, Llc
      • 6.5.12.1. Company overview
      • 6.5.12.2. Financial performance
      • 6.5.12.3. Product benchmarking
      • 6.5.12.4. Strategic initiatives
    • 6.5.13. HTL Biotechnology
      • 6.5.13.1. Company overview
      • 6.5.13.2. Financial performance
      • 6.5.13.3. Product benchmarking
      • 6.5.13.4. Strategic initiatives
    • 6.5.14. Shiseido Company, Limited
      • 6.5.14.1. Company overview
      • 6.5.14.2. Financial performance
      • 6.5.14.3. Product benchmarking
      • 6.5.14.4. Strategic initiatives
    • 6.5.15. Bloomage Biotechnology Corporation Limited
      • 6.5.15.1. Company overview
      • 6.5.15.2. Financial performance
      • 6.5.15.3. Product benchmarking
      • 6.5.15.4. Strategic initiatives
    • 6.5.16. LG Life Sciences Ltd (LG Chem.)
      • 6.5.16.1. Company overview
      • 6.5.16.2. Financial performance
      • 6.5.16.3. Product benchmarking
      • 6.5.16.4. Strategic initiatives
    • 6.5.17. Maruha Nichiro, Inc.
      • 6.5.17.1. Company overview
      • 6.5.17.2. Financial performance
      • 6.5.17.3. Product benchmarking
      • 6.5.17.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global hyaluronic acid market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America hyaluronic acid market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 7 U.S. hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 9 Mexico hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe hyaluronic acid market, by country, 2018 - 2030 (USD Million)
  • Table 11 Europe hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 12 UK hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 13 Germany hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 14 France hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 15 Italy hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 16 Spain hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 17 Norway hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 18 Denmark hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 19 Sweden hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific hyaluronic acid market, by country, 2018 - 2030 (USD Million)
  • Table 21 Asia Pacific hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 22 Japan hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 23 China hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 24 India hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 25 Australia hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 26 South Korea hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 27 Thailand hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 28 Latin America hyaluronic acid market, by country, 2018 - 2030 (USD Million)
  • Table 29 Latin America hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 30 Brazil hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 31 Argentina hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa Docetaxel market, by country, 2018 - 2030 (USD Million)
  • Table 33 Middle East & Africa hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 34 South Africa hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 35 Saudi Arabia hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 36 UAE hyaluronic acid market, by application, 2018 - 2030 (USD Million)
  • Table 37 Kuwait hyaluronic acid market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Hyaluronic Acid market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach and application outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Hyaluronic Acid market dynamics
  • Fig. 12 Hyaluronic Acid market: Porter's five forces analysis
  • Fig. 13 Hyaluronic Acid market: PESTLE analysis
  • Fig. 14 Product market, 2018 - 2030 (USD Million)
  • Fig. 15 Dermal fillers market, 2018 - 2030 (USD Million)
  • Fig. 16 Osteoarthritis market, 2018 - 2030 (USD Million)
  • Fig. 17 Ophthalmic market, 2018 - 2030 (USD Million)
  • Fig. 18 Vesicoureteral reflux market, 2018 - 2030 (USD Million)
  • Fig. 19 Regional marketplace: Key takeaways
  • Fig. 20 North America hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 21 U.S. country dynamics
  • Fig. 22 U.S. hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 23 Canada country dynamics
  • Fig. 24 Canada hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 25 Mexico country dynamics
  • Fig. 26 Mexico hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 27 Europe hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 28 UK country dynamics
  • Fig. 29 UK hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 30 Germany country dynamics
  • Fig. 31 Germany hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 32 France country dynamics
  • Fig. 33 France hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 34 Italy country dynamics
  • Fig. 35 Italy hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 36 Spain country dynamics
  • Fig. 37 Spain hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 38 Norway country dynamics
  • Fig. 39 Norway hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 40 Sweden country dynamics
  • Fig. 41 Sweden hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark country dynamics
  • Fig. 43 Denmark hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 45 Japan country dynamics
  • Fig. 46 Japan hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 47 China country dynamics
  • Fig. 48 China hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 49 India country dynamics
  • Fig. 50 India hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 51 Australia country dynamics
  • Fig. 52 Australia hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea country dynamics
  • Fig. 54 South Korea hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand country dynamics
  • Fig. 56 Thailand hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil country dynamics
  • Fig. 59 Brazil hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina country dynamics
  • Fig. 61 Argentina hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 62 MEA hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa country dynamics
  • Fig. 64 South Africa hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia country dynamics
  • Fig. 66 Saudi Arabia hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 67 UAE country dynamics
  • Fig. 68 UAE hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 69 Kuwait country dynamics
  • Fig. 70 Kuwait hyaluronic acid market, 2018 - 2030 (USD Million)
  • Fig. 71 Company categorization
  • Fig. 72 Company market position analysis
  • Fig. 73 Strategic framework